Abstract
Introduction Anastomotic leak is a dreaded complication following gastrointestinal (GI) anastomotic surgery. It increases morbidity and mortality of patients undergoing GI surgery. However, there is paucity of data on the incidence and risk factors of anastomotic leak following gastrointestinal surgery in Uganda. The main objective of this study was to determine the incidence and risk factors of anastomotic leak following gastrointestinal surgery in Mulago Hospital.
Methods We consecutively recruited adult patients admitted to the general surgery wards in Mulago Hospital, 24 hours following gastrointestinal surgery. The recruitment process started on 22nd April 2024 and ended on 11th July 2024. The participants provided informed written consent prior to enrolment into the study. Patient related factors including preoperative anemia, preoperative albumin level, and ASA status were recorded on entry, while the outcome (anastomotic leak) was obtained upon 14 day’s follow-up. Data were analysed using SPSS version 26. Multivariate logistic regression was used to determine the independent risk factors for anastomotic leak, p< 0.05 was considered statistically significant.
Results Eighty-five participants were studied. The incidence of anastomotic leak was 8.2% (n=7). Hemoglobin level less than 10 g/dl was the only independent predictor for anastomotic leak in this study. (RR, 8.15; 95% C.I, 1.16 - 57.48; p=0.035).
Conclusion The incidence of anastomotic leak in Mulago National Referral Hospital was low. Low Hemoglobin (Hb<10g/dl) was associated with increased rates of anastomotic leak.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Makerere University School of Medicine Ethics committee gave approval for this work. Mak-SOMREC-2024-899
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The abstract and some sections within the methods were adjusted to include the exact dates of the participant recruitment and the form of informed consent obtained from the participants
Data Availability
All data produced in the present work are contained in the manuscript
